Vol.57 No.S-2 July 2009

Phase I study of levofloxacin in healthy and elderly volunteers

Kohya Shiba, Hiroyuki Fukase and Atsushi Sugiyama

Jpn. J. Chemother. 57 (S-2): 1-11, 2009

Levofloxacin 500 mg pharmacokinetics in patients with impaired renal function

Kazushige Hanaoka, Kazuya Kawahara, Satoru Nagashima and Seiji Hori

Jpn. J. Chemother. 57 (S-2): 12-19, 2009

Clinical response of levofloxacin 500 mg qd to respiratory tract infection

Shigeru Kohno, Akira Watanabe, Nobuki Aoki, Yoshihito Niki, Junichi Kadota, Jiro Fujita, Katsunori Yanagihara, Mitsuo Kaku and Seiji Hori

Jpn. J. Chemother. 57 (S-2): 20-33, 2009

Clinical response of levofloxacin 500 mg qd to complicated urinary tract infection -efficacy of 7- and 14-day administration-

Tetsuro Matsumoto, Mitsuru Yasuda, Soichi Arakawa, Koichi Monden, Tetsuro Muratani and Seiji Hori

Jpn. J. Chemother. 57 (S-2): 34-46, 2009

Population pharmacokinetics and pharmacodynamics of 500 mg oral dose levofloxacin in respiratory tract infection patients

Yusuke Tanigawara, Takako Shimizu and Kyoichi Totsuka

Jpn. J. Chemother. 57 (S-2): 47-54, 2009